<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.1" specific-use="sps-1.8" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
	<front>
		<journal-meta>
			<journal-id journal-id-type="publisher-id">abc</journal-id>
			<journal-title-group>
				<journal-title>Acta Biológica Colombiana</journal-title>
				<abbrev-journal-title abbrev-type="publisher">Acta biol.Colomb.</abbrev-journal-title>
			</journal-title-group>
			<issn pub-type="ppub">0120-548X</issn>
			<publisher>
				<publisher-name>Universidad Nacional de Colombia, Facultad de Ciencias, Departamento de Biología</publisher-name>
			</publisher>
		</journal-meta>
		<article-meta>
			<article-id pub-id-type="doi">10.15446/abc.v24n3.79351</article-id>
			<article-categories>
				<subj-group subj-group-type="heading">
					<subject>Artículos</subject>
				</subj-group>
			</article-categories>
			<title-group>
				<article-title>CELL CULTURE ISOLATION OF HEPATITIS E VIRUS GENOTYPE 3 STRAIN OBTAINED FROM HUMAN FECES</article-title>
				<trans-title-group xml:lang="es">
					<trans-title>Aislamiento de una cepa genotipo 3 del virus de la hepatitis E obtenida de heces humanas</trans-title>
				</trans-title-group>
			</title-group>
			<contrib-group>
				<contrib contrib-type="author">
					<name>
						<surname>QUINTERO-GIL</surname>
						<given-names>Carolina</given-names>
					</name>
					<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
					<xref ref-type="corresp" rid="c1"><sup>*</sup></xref>
					<xref ref-type="fn" rid="fn1">†</xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>MIRAZO</surname>
						<given-names>Santiago</given-names>
					</name>
					<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
					<xref ref-type="fn" rid="fn1">†</xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>PARRA-SUESCÚN</surname>
						<given-names>Jaime</given-names>
					</name>
					<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>LÓPEZ-HERRERA</surname>
						<given-names>Albeiro</given-names>
					</name>
					<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>MAINARDI</surname>
						<given-names>Victoria</given-names>
					</name>
					<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>ARBIZA</surname>
						<given-names>Juan</given-names>
					</name>
					<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>ORDÚZ</surname>
						<given-names>Sergio</given-names>
					</name>
					<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
				</contrib>
			</contrib-group>
			<aff id="aff1">
				<label>1</label>
				<institution content-type="original"> Grupo Biología Funcional, Escuela de Biociencias, Universidad Nacional de Colombia Sede Medellín, Cra. 65 n°. 59a - 110, Medellín, Colombia.</institution>
				<institution content-type="normalized">Universidad Nacional de Colombia</institution>
				<institution content-type="orgname">Universidad Nacional de Colombia Sede Medellín</institution>
				<addr-line>
					<city>Medellín</city>
				</addr-line>
				<country country="CO">Colombia</country>
			</aff>
			<aff id="aff2">
				<label>2</label>
				<institution content-type="original"> Sección Virología, Facultad de Ciencias, Universidad de la República, Iguá 4225, 11400 Montevideo, Uruguay.</institution>
				<institution content-type="normalized">Universidad de la República</institution>
				<institution content-type="orgname">Universidad de la República</institution>
				<addr-line>
					<city>Montevideo</city>
				</addr-line>
				<country country="UY">Uruguay</country>
			</aff>
			<aff id="aff3">
				<label>3</label>
				<institution content-type="original"> Grupo Biodiversidad y Genética Molecular -BIOGEM, Facultad de Ciencias Agrarias, Universidad Nacional de Colombia Sede Medellín, Cra. 65 n°. 59a - 110, Medellín, Colombia.</institution>
				<institution content-type="normalized">Universidad Nacional de Colombia</institution>
				<institution content-type="orgname">Universidad Nacional de Colombia Sede Medellín</institution>
				<addr-line>
					<city>Medellín</city>
				</addr-line>
				<country country="CO">Colombia</country>
			</aff>
			<aff id="aff4">
				<label>4</label>
				<institution content-type="original"> Programa Nacional de Trasplante Hepático, Hospital Central de las Fuerzas Armadas, Av. 8 de Octubre 3060, 11600, Montevideo, Uruguay.</institution>
				<institution content-type="normalized">Universidad de la República</institution>
				<institution content-type="orgname">Hospital Central de las Fuerzas Armadas</institution>
				<addr-line>
					<city>Montevideo</city>
				</addr-line>
				<country country="UY">Uruguay</country>
			</aff>
			<author-notes>
				<corresp id="c1">
					<email>*</email><bold>
 <italic>For correspondence:</italic> 
</bold><email>dicquinterogi@unal.edu.co</email>
				</corresp>
				<fn fn-type="other" id="fn4">
					<p>
						<graphic xlink:href="0120-548X-abc-24-03-503-g001.jpg"/> Licencia Creative Commons.</p>
				</fn>
			</author-notes>
			<pub-date pub-type="collection">
				<season>Sep-Dec</season>
				<year>2019</year>
			</pub-date>
			<volume>24</volume>
			<issue>3</issue>
			<fpage>503</fpage>
			<lpage>508</lpage>
			<history>
				<date date-type="received">
					<day>26</day>
					<month>04</month>
					<year>2019</year>
				</date>
				<date date-type="rev-recd">
					<day>31</day>
					<month>05</month>
					<year>2019</year>
				</date>
				<date date-type="accepted">
					<day>04</day>
					<month>07</month>
					<year>2019</year>
				</date>
			</history>
			<permissions>
				<license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-sa/4.0/" xml:lang="en">
					<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License</license-p>
				</license>
			</permissions>
			<abstract>
				<title>ABSTRACT</title>
				<p>Hepatitis E virus (HEV) is considered one of the leading causes of acute viral hepatitis worldwide, and about 20 million infections and approximately 57 000 deaths occurred every year. However, little is known about the replicative virus cycle due to the absence of a consensus cell culture model. A549 cell line is considered susceptible to HEV genotype 3, however, both viral strain and cell culture conditions could affect the viral isolation in vitro. The objective of this work was to isolate in vitro an HEV-3 strain obtained from human feces. To this, a genotype 3 HEV strain previously identified by genetic characterization was inoculated in A549 monolayers, and incubated for two hours at 37 °C. Five days post-infection, cells were passaged (subcultured) for the first time, and serial passages were done on average every four days during 41 days. HEV replication was evaluated through RT-qPCR in each passage, and reinfection of the cell line with the viral progeny derived from A549 infected monolayers was assessed through immunofluorescence and RT-qPCR. Viral RNA was detected in each passage from infected monolayers, and the highest amount was found after 26 days (2 x 106 copies/µL). In reinfection assay, capsid antigen was detected perinuclearly and forming foci, and 1x104 copies/µL of viral RNA was detected after 96 hours post infection. This shows that HEV recovered from the cell lysate monolayers was infectious. This viral isolate offers a critical tool to study the unknown aspect of HEV infection.</p>
			</abstract>
			<trans-abstract xml:lang="es">
				<title>RESUMEN</title>
				<p>El virus de la hepatitis E (HEV) se considera como una de las principales causas de hepatitis viral aguda en el mundo; cada año ocurren aproximadamente 20 millones de infecciones y 57 000 muertes. Debido a la ausencia de un modelo de cultivo celular consenso, se sabe poco sobre el ciclo replicativo del virus. La línea celular A549 se considera susceptible al genotipo 3 de HEV, pero tanto la cepa viral como las condiciones del cultivo celular podrían afectar el aislamiento viral in vitro. Por tanto nos propusimos aislar in vitro una cepa genotipo 3 del HEV. Para ello, se inocularon células A549 con una cepa HEV-3 identificada previamente por caracterización genética, y se incubó durante dos horas a 37 °C. Cinco días después de la infección, las células se pasaron (subcultivaron) por primera vez, y se realizaron pases seriados cada cuatro días en promedio, durante 41 días. En cada pase se evalúo la replicación del HEV mediante RT-qPCR. La reinfección de la línea celular con progenie viral derivada de monocapas de A549 infectadas se evaluó mediante inmunofluorescencia y RT-qPCR. Se detectó ARN viral en cada pase a partir de monocapas, y el pico máximo se alcanzó a los 26 días post infección (2 x 106 copias/µL). En el ensayo de reinfección, se detectó antígeno de cápside perinuclearmente y formando focos, y se detectaron 1 x 104 copias/µL de RNA viral a las 96 horas post infección. El HEV recuperado de lisado de monocapas fue infeccioso. Este aislado viral ofrece una herramienta importante para estudiar aspectos desconocidos de la infección por HEV.</p>
			</trans-abstract>
			<kwd-group xml:lang="en">
				<title>Keywords:</title>
				<kwd>A549 cells</kwd>
				<kwd>hepevirus</kwd>
				<kwd>isolation</kwd>
				<kwd>RNA virus</kwd>
			</kwd-group>
			<kwd-group xml:lang="es">
				<title>Palabras clave:</title>
				<kwd>Aislamiento</kwd>
				<kwd>células A549</kwd>
				<kwd>hepevirus</kwd>
				<kwd>virus ARN</kwd>
			</kwd-group>
			<counts>
				<fig-count count="2"/>
				<table-count count="0"/>
				<equation-count count="0"/>
				<ref-count count="20"/>
				<page-count count="6"/>
			</counts>
		</article-meta>
	</front>
	<body>
		<sec sec-type="intro">
			<title>INTRODUCTION</title>
			<p>Hepatitis E is considered the main cause of viral acute liver failure in developing countries, and nowadays, industrialized countries had been affected by autochthonous infections (<xref ref-type="bibr" rid="B2">Donnelly <italic>et al.,</italic> 2017</xref>). Hepatitis E is caused by the hepatitis E Virus (HEV), a non-envelope, positive sense, single strain RNA virus, and possessed three open reading frames: ORF1, ORF2 and ORF3, coding for viral polymerase, capsid and multifunctional small phosphoprotein, respectively (<xref ref-type="bibr" rid="B13">Rogée <italic>et al.,</italic> 2013</xref>), and has five known genotypes affecting humans (genotypes 1 and 2) or both humans and animals (genotypes 3, 4 and 7) (<xref ref-type="bibr" rid="B15">Sridhar <italic>et al.,</italic> 2017</xref>). HEV infection has been classified as a food-borne zoonosis and the main transmission pathway is through consumption of contaminated water or contaminated food, particularly undercooked or raw pork meat (Rogée <italic>et al.,</italic> 2013; Donnelly <italic>et al.,</italic> 2017).</p>
			<p>Antiviral treatment is non-specific, and ribavirin has become the first-line drug for both, acute and chronic HEV infection because the combined therapy with pegylated interferon is contraindicated in immunosuppressed patients (<xref ref-type="bibr" rid="B1">Debing <italic>et al.,</italic> 2014</xref>). Resistance to ribavirin has been reported and consequently treatment failure; additionally, anemia is one of the side effects of ribavirin therapy (<xref ref-type="bibr" rid="B2">Donnelly <italic>et al.,</italic> 2017</xref>), which is of particular concern for vulnerable patients (pregnant women and immunocompromised), for whom ribavirin could be toxic; therefore, effective and safer antiviral agents against HEV are needed (<xref ref-type="bibr" rid="B4">Hui <italic>et al.,</italic> 2016</xref>). However, without a proper <italic>in vitro</italic> culture system for virus replication, the search for new antiviral compounds is limited.</p>
			<p>Hepatitis E Virus life cycle is poorly understood due to the absence of an effective cell culture system (<xref ref-type="bibr" rid="B13">Rogée <italic>et al.,</italic> 2013</xref>), but some attempts to propagate the virus <italic>in vitro</italic> have been done. Primary hepatocytes cultures and pluripotent stem cell (PSC)-derived hepatocytes have been used as effective systems to viral propagation (<xref ref-type="bibr" rid="B3">Helsen <italic>et al.,</italic> 2016</xref>; <xref ref-type="bibr" rid="B20">Zhang and Wang, 2016</xref>); however, both primary and stem cells are challenging to obtain and to maintain. Continuous cell lines from different origins such as human hepatoma, colon adenocarcinoma, and lung carcinoma had been used (Zhang and Wang, 2016), but high replication efficiency has not been achieved, and cDNA infectious clones had been used to obtain success <italic>in vitro</italic> infections (<xref ref-type="bibr" rid="B16">Shukla <italic>et al.,</italic> 2012</xref>; <xref ref-type="bibr" rid="B12">Qi <italic>et al.,</italic> 2015</xref>; <xref ref-type="bibr" rid="B5">Johne <italic>et al.,</italic> 2016</xref>). In spite that human lung carcinoma A549 is a non-hepatic cell line, it is the model most used to sustain HEV <italic>in vitro</italic> infection, and it has been proved that this cell line supports replication of genotypes 1 and 3 (<xref ref-type="bibr" rid="B7">Li <italic>et al.,</italic> 2016</xref>), and also a persistently HEV-infected A549 cell line has been obtained (Johne <italic>et al.,</italic> 2016). The aim of this study was to establish an <italic>in vitro</italic> model of HEV infection for antiviral assays, To this, the A549 cell line was used to isolate and to propagate HEV obtained from a human feces sample of a patient with acute hepatitis, A549 infection with isolated virus was assessed and presence of viral RNA and capsid antigen were detected into the cells after 96 hours post-infection, confirming that HEV recovered from the cell lysate monolayers was infectious.</p>
		</sec>
		<sec sec-type="materials|methods">
			<title>MATERIALS AND METHODS</title>
			<sec>
				<title>Cell culture and virus</title>
				<p>Human lung carcinoma A549 cells were obtained from the American Type Culture Collection (ATCC<sup>®</sup> CCL-185<sup>TM</sup>) and were grown at 37 °C with 5 % CO<sub>2</sub> atmosphere in Dulbecco's modified Eagle's maintenance medium (DMEM, 100 U/mL penicillin, 100 mg/mL streptomycin and 5 % fetal bovine serum). The fecal sample was kindly donated by Servicio de Trasplante Hepático del Hospital Central de las Fuerzas Armadas, Montevideo, Uruguay, and it was obtained from a human feces sample of a South American patient in the acute phase. The sample was previously characterized extracting RNA (TRIzol, LifeTechnologies) from 1 mL of a 10 % suspension of fecal material in phosphate-buffered saline (PBS, Gibco<sup>®</sup> No Calcium, No Magnesium). To detect the viral genome, an RT-PCR was performed with the 5' end of ORF1 as the target, according to <xref ref-type="bibr" rid="B10">Mirazo <italic>et al.,</italic> (2013)</xref>. For genotyping, a phylogenetic analysis was implemented using the Maximum-Likelihood method and the Tamura-Nei evolutionary model, using MEGA v6 (Mainardi <italic>et al.,</italic> 2018, submitted).</p>
			</sec>
			<sec>
				<title>Virus isolation</title>
				<p>For virus isolation, 50 - 70 % -confluent A549 cell monolayers grown in six-well plates (Falcon<sup>®</sup>) were washed three times with 1 mL PBS. The fecal sample was diluted 2-fold in PBS and filtered through acrodisc syringe filters with a pore size of 0.22 μm (Millex-GV; Millipore Corp., Bedford, MA). A549 monolayers were infected with 0.5 mL of the filtrated sample containing 5.85 x 10<sup>5</sup> RNA copies/µL per well at 37 °C and 5 % CO<sub>2</sub> atmosphere. After two hours the inoculum was removed, cells were washed three times with PBS, and then 2.5 mL of cell maintenance medium was added to each well and incubated at 37 °C in a humidified 5 % CO<sub>2</sub> atmosphere. Four days post-infection (dpi) cells were passaged for the first time. Cells were washed, dispersed with 0.25 % trypsin (500 μL), diluted 4-fold in fresh maintenance medium, and 1 mL was added to a new cell well. Infected cells were thus passaged serially and tested by RT-PCR every 3 - 5 days for 41 days. The infected cell cultures were examined daily under an inverted microscope (Nikon TS 100 F), but no specific cytopathic effect was observed. Viral stocks were obtained from infected monolayers by two freeze-thaw cycles in liquid nitrogen, and viruses were quantified by determining the viral genome copy number by RT-qPCR and stored at -80 °C until use.</p>
			</sec>
			<sec>
				<title>Viral RNA extraction and quantification</title>
				<p>For total RNA isolation, TRIzol (Invitrogen<sup>®</sup>) was used according to the manufacturer's directions. Then, RT-PCR was performed targeting a region within the ORF1 (partial methyltransferase gene and hypervariable region) as previously described (<xref ref-type="bibr" rid="B10">Mirazo <italic>et al.,</italic> 2013</xref>). For RT-qPCR we used the forward (JVHEVF; 5'-GGTGGTTTCTGGGGTGAC-3') and reverse primers (JVHEVR; 5'-AGGGGTTGGTTGGATGAA-3') targeting a region within the ORF3 previously reported (<xref ref-type="bibr" rid="B6">Jothikumar <italic>et al.,</italic> 2006</xref>), and the 25 μL mixtures were incubated at 42 °C for 30 minutes, followed by 95 °C for 10 minutes, and 39 cycles at 95 °C for 20 s, 60 °C for 20 s, and 72 °C for 45 s. A melting curve was run to verify the specificity of the products and was performed at 95 °C for 15 s, 60 °C for 15 s and 95 °C for 15 s, collecting data every 0.2 s. A 10-fold serial dilution of the RNA standards (10<sup>2</sup>10<sup>8</sup> copies) was used for the quantitation of viral genome copies numbers (Mirazo <italic>et al.,</italic> 2018). The RT-qPCR analysis was performed in the ABI 7500 Real-Time PCR System. All procedures were performed by triplicate and data are expressed as means (±S.D.).</p>
			</sec>
			<sec>
				<title>Infection assay</title>
				<p>To test if viral stock obtained from infected monolayers by two freeze-thaw cycles in liquid nitrogen could be able to infect fresh monolayers, 1 x 10<sup>5</sup> A549 cells were seeded in 24 well plates (Falcon<sup>®</sup>), 24 hours before viral infection. Then, cells were treated during two hours at 37 °C with two different inoculum concentrations obtained from cell lysates prepared in serum-free media (1 x 10<sup>4</sup> or 1 x 10<sup>5</sup> RNA copies/µL per well, by duplicate in two independent experiments). After that, the viral inoculum was removed and 500 μL of maintenance medium was added to each well. 96 hours post-infection (hpi), viral RNA and antigen detection were done by RT-qPCR and immunofluorescence assays (IFA), respectively. For IFA, cells were fixed with 200 μL per well of 75 % ethanol for 15 minutes; then cells were washed twice with PBS and treated with 200 μL of 0.1 % triton X-100 prepared in PBS. After blocking non-specific binding sites with 1 % bovine serum albumin (BSA) diluted in PBS, a 1:200 dilution of commercial monoclonal antibody against capsid antigen was added (ABCam, UK). Antibody was incubated for one hour at 37 °C and then washed twice in BSA-PBS prior incubation with FITC-labelled secondary antibody (goat anti-mouse IgG ABCam) for one hour at 37 °C. After incubation with the secondary antibody, cells were washed and DAPI diluted 1:100 in PBS was added for five minutes. Cells were rewashed and examined for the presence of HEV antigen by using an inverted fluorescence microscope (Olympus IX81, filters U-MNUA2, 360 - 370 nm, and U-MNIBA3 470 - 495 nm).</p>
			</sec>
		</sec>
		<sec sec-type="results">
			<title>RESULTS</title>
			<sec>
				<title>Detection of HEV RNA in infected cells monolayers</title>
				<p>HEV positive A549 cell cultures were found by RT-PCR after 26 dpi with serial passages every three to four days (<xref ref-type="fig" rid="f1">Figure 1</xref>a). The viral concentration of each day of sampling was quantified. The highest RNA copies number was found after 26 dpi (2 x 10<sup>6</sup> RNA copies/µL) and viral RNA concentration decrease after day 35. No specific cytopathic effect was observed, and the evaluation finished on day 41 (<xref ref-type="fig" rid="f1">Figure 1</xref>b). Capsid antigen and HEV RNA was detected in A549 cells infected with the isolated virus HEV is a highly tricky virus to isolate and for this reason, we tested if the viral stock isolated after 26 dpi were infectious to new A549 cells. Cells were treated with two viral concentrations prepared in serum-free media (1 x 10<sup>4</sup> and 1 x 10<sup>5</sup> copies/µL), and after 96 hpi, capsid antigen was detected perinuclearly and forming foci on A549 cells infected with 1 x 10<sup>4</sup> copies/µL (<xref ref-type="fig" rid="f2">Figure 2</xref>a) and viral RNA was detected in cell monolayers but no in supernatants. Of note, no statistically significative difference in viral genome copy number between the two viral concentrations used was found <italic>(p</italic> = 0.68 Mann-Whitney. U-test) (<xref ref-type="fig" rid="f2">Figure 2</xref>b), indicating that this dilution was infectious.</p>
				<p>
					<fig id="f1">
						<label>Figure 1</label>
						<caption>
							<title>Human feces diluted in PBS were used to isolate HEV in A549 cell line. a. HEV RNA was detected by RT-PCR of a 287 bp ORF1 partial sequence. Viral RNA was detected in cell monolayers after 26 (lane 3) and 41 (lane 4) days post-infection. RNA extracted directly from PBS diluted feces was used as a positive control (lane 8). Non-infected cell cultures (lanes 2, 5 and 6) were tested as a control. Water was used as RT-PCR negative control (lane 7). Thermo Scientific™ GeneRuler™ 100 bp DNA Ladder (lane 1). b. Highest genome copy number of intracellular HEV was achieved at 26 days post-infection and decreased in the subsequent days.</title>
						</caption>
						<graphic xlink:href="0120-548X-abc-24-03-503-gf1.gif"/>
					</fig>
				</p>
				<p>
					<fig id="f2">
						<label>Figure 2</label>
						<caption>
							<title>Infection assay. A549 cells were inoculated with 1 x 10<sup>4</sup> or 1 x 10<sup>5</sup> copies/µL of the 26 dpi viral stock during 96 hours. a. HEV capsid antigen (ORF-2) was detected in infected cell cultures by indirect immunofluorescence using a monoclonal antibody, followed by a FITC conjugated secondary antibody (green). Nuclei were stained with DAPI (blue). Non-infected cell cultures (mock) were used as a control. b. Viral RNA was detected at 96 hpi, and no statistically difference were found between the two inocula <italic>(p</italic> = 0.68, Mann-Whitney. U-test). The values are representative of two independent experiments with two replicates each (n = 4). Error bars represent the standard deviation (SD)</title>
						</caption>
						<graphic xlink:href="0120-548X-abc-24-03-503-gf2.gif"/>
					</fig>
				</p>
			</sec>
		</sec>
		<sec sec-type="discussion">
			<title>DISCUSSION</title>
			<p>Hepatitis E virus life cycle is not well understood due to the difficulty to obtain a productive viral infection <italic>in vitro.</italic> Besides, the few available systems are cell and virus dependent, and in the last 10 years only four cell lines without previous exposure to HEV were found suitable for viral production (<xref ref-type="bibr" rid="B19">Von Nordheim <italic>et al.,</italic> 2016</xref>; <xref ref-type="bibr" rid="B20">Zhang and Wang, 2016</xref>), and recently it was reported the isolation of wild type strains with high replicative capacity <italic>in vitro</italic> (<xref ref-type="bibr" rid="B14">Schemmerer <italic>et al.,</italic> 2019</xref>).</p>
			<p>A549, HEPG2/C3A, PLC/PRF/5, Huh-7 Lunet BLR and MRC-5 cell lines support HEV infection with the virus strain 47 832c of genotype 3, but the higher virus productivity was detected in A549 cell line with 7.3 x 10<sup>7</sup> copies/mL after 30 days post-infection (<xref ref-type="bibr" rid="B18">Takahashi <italic>et al.,</italic> 2012</xref>). For the viral strain JE03-1760F also belonging to genotype 3, viral loads reached 1 x 10<sup>8</sup> copies/mL, but after 52 days after inoculation (<xref ref-type="bibr" rid="B8">Lorenzo <italic>et al.,</italic> 2008</xref>). Under different culture conditions, differences in cell line phenotypes tend to appear, and this could explain why the highest viral genome copy detection in our model was achieved after 26 dpi, in contrast to the other models. Of note, in most of the available cell models, viral recovery had been done from the supernatant (<xref ref-type="bibr" rid="B9">Meister <italic>et al.,</italic> 2019</xref>), in contrast to the model used in this study in which viral recovery was obtained from cell monolayers; however, in the study using A549 cells, viral recovery was achieved after 30 days of culturing and the sample was obtained from a human patient serum (Takahashi <italic>et al.,</italic> 2010).</p>
			<p>According to this, origin and type of sample is another crucial factor for HEV isolation. It has been reported that genotypes 1, 3 and 4 isolated from human's feces have been successfully propagated and detected between three to 26 days after infecting the cells with at least 1.0 x 10<sup>4</sup> copies/ mL (<xref ref-type="bibr" rid="B20">Zhang and Wang, 2016</xref>). Similarly, the sample we used belonged to genotype 3 and was obtained from human feces (Mainardi <italic>et al.,</italic> 2018, submitted). Animal sample sources as serum, liver and, feces have been reported as adequate for genotype 3 viral isolation, releasing viral progeny to the cell supernatant with 7.3 x 10<sup>7</sup> RNA copies/mL after 30 dpi (<xref ref-type="bibr" rid="B18">Takahashi <italic>et al.,</italic> 2012</xref>). In sharp contrast, we could not detect viral RNA in the supernatant, but after 26 dpi, viral RNA into the cells reached 2 x 10<sup>6</sup> copies/µL (<xref ref-type="fig" rid="f1">Figure 1</xref>b).</p>
			<p>Ferret <italic>(Mustela putorius)</italic> HEV, another member of the <italic>Hepeviridae</italic> family, has been used to understand the viral replication cycle. In this case, stool suspension was inoculated in PLC/PRF/5 cells, and viral particles were found associated with cell membranes, and in agreement with our findings, the capsid antigen was in proximity to the nucleus.</p>
			<p>Similarly, 1 x 10<sup>6</sup> RNA copies/mL were found after 32 days post-inoculation (<xref ref-type="bibr" rid="B7">Li <italic>et al.,</italic> 2016</xref>).</p>
			<p>
				<xref ref-type="bibr" rid="B18">Takahashi <italic>etal.,</italic> (2012)</xref> demonstrated that HEV viral progeny obtained from A549 infected cells with viral particle amounts up to 2 x 10<sup>4</sup> genome copies/well could support efficient multiplication of HEV in A549 unexposed cells, reaching 7.3 x 10<sup>7</sup> copies/mL after 30 dpi. Our HEV strain was also able to infect A549 cells and both viral RNA and capsid antigen were detected after 96 hpi when new cell cultures were inoculated with 1 x 10<sup>4</sup> RNA copies (<xref ref-type="fig" rid="f2">Figure 2</xref>b). Like our model, cell supernatants derived from PSC-hepatocytes were used to infect HepG3/C3A and 2 x 10<sup>5</sup> RNA copies/mL of intracellular viral RNA was detected after 12 dpi (<xref ref-type="bibr" rid="B3">Helsen <italic>et al.,</italic> 2016</xref>).</p>
		</sec>
		<sec sec-type="conclusions">
			<title>CONCLUSIONS</title>
			<p>Understanding the biology of the HEV life cycle without a proper cell culture system is a difficult task, and therefore, antiviral drug design is still a challenge, despite searching for new antiviral molecules against HEV is a matter of significant interest in the scientific community. Here we report the isolation of HEV genotype 3 on A549 cells with genome detection after serial passages performed every 4 days. The isolated obtained after 26 dpi, was also able to infect non previously exposed A549 cell, and genome and viral protein detection after 96 hours were achieved. This viral isolate could be a helpful tool to study the HEV life cycle and could be used for antiviral drug evaluation.</p>
		</sec>
	</body>
	<back>
		<ack>
			<title>AKNOWDLEGMENTS</title>
			<p>Departamento Administrativo de Ciencia, Tecnología e Innovación COLCIENCIAS, granted Corresponding author PhD Scholarship No. 567-2012. Corresponding author fellowship to Sección Virología, Universidad de la República, Montevideo, Uruguay was kindly supported by United Nations University, Biotechnology Programme for Latin America and the Caribbean (UNU-BIOLAC), Red de Macrouniversidades de América Latina y el Caribe and Universidad Nacional de Colombia sede Medellín.</p>
		</ack>
		<ref-list>
			<title><bold>REFERENCES</bold></title>
			<ref id="B1">
				<mixed-citation>Debing Y, Emerson SU, Wang Y, Pan Q, Balzarini J, Dallmeier K, <italic>et al</italic>. Ribavirin inhibits <italic>In vitro</italic> hepatitis E virus replication through depletion of cellular GTP pools and is moderately synergistic with alpha interferon. Antimicrob. Agents Chemother. 2014;58(1):267-273. Doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/AAC.01795-13">https://doi.org/10.1128/AAC.01795-13 </ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Debing</surname>
							<given-names>Y</given-names>
						</name>
						<name>
							<surname>Emerson</surname>
							<given-names>SU</given-names>
						</name>
						<name>
							<surname>Wang</surname>
							<given-names>Y</given-names>
						</name>
						<name>
							<surname>Pan</surname>
							<given-names>Q</given-names>
						</name>
						<name>
							<surname>Balzarini</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Dallmeier</surname>
							<given-names>K</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>Ribavirin inhibits In vitro hepatitis E virus replication through depletion of cellular GTP pools and is moderately synergistic with alpha interferon</article-title>
					<source>Antimicrob. Agents Chemother</source>
					<year>2014</year>
					<volume>58</volume>
					<issue>1</issue>
					<fpage>267</fpage>
					<lpage>273</lpage>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/AAC.01795-13">https://doi.org/10.1128/AAC.01795-13 </ext-link>
				</element-citation>
			</ref>
			<ref id="B2">
				<mixed-citation>Donnelly MC, Scobie L, Crossan CL, Dalton H, Hayes PC, Simpson KJ. Hepatitis E: a concise review of virology, epidemiology, clinical presentation and therapy. Aliment. Pharmacol. Ther. 2017;46(2):126-141. Doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/apt.14109">https://doi.org/10.1111/apt.14109</ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Donnelly</surname>
							<given-names>MC</given-names>
						</name>
						<name>
							<surname>Scobie</surname>
							<given-names>L</given-names>
						</name>
						<name>
							<surname>Crossan</surname>
							<given-names>CL</given-names>
						</name>
						<name>
							<surname>Dalton</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Hayes</surname>
							<given-names>PC</given-names>
						</name>
						<name>
							<surname>Simpson</surname>
							<given-names>KJ</given-names>
						</name>
					</person-group>
					<article-title>Hepatitis E: a concise review of virology, epidemiology, clinical presentation and therapy. Aliment. Pharmacol</article-title>
					<source>Ther</source>
					<year>2017</year>
					<volume>46</volume>
					<issue>2</issue>
					<fpage>126</fpage>
					<lpage>141</lpage>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/apt.14109">https://doi.org/10.1111/apt.14109</ext-link>
				</element-citation>
			</ref>
			<ref id="B3">
				<mixed-citation>Helsen N, Debing Y, Paeshuyse J, Dallmeier K, Boon R, Coll M, <italic>et al</italic>. Stem cell-derived hepatocytes: A novel model for hepatitis e virus replication. J. Hepatol. 2016;64(3):565-573. Doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jhep.2015.11.013">https://doi.org/10.1016/j.jhep.2015.11.013</ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Helsen</surname>
							<given-names>N</given-names>
						</name>
						<name>
							<surname>Debing</surname>
							<given-names>Y</given-names>
						</name>
						<name>
							<surname>Paeshuyse</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Dallmeier</surname>
							<given-names>K</given-names>
						</name>
						<name>
							<surname>Boon</surname>
							<given-names>R</given-names>
						</name>
						<name>
							<surname>Coll</surname>
							<given-names>M</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>Stem cell-derived hepatocytes: A novel model for hepatitis e virus replication</article-title>
					<source>J. Hepatol</source>
					<year>2016</year>
					<volume>64</volume>
					<issue>3</issue>
					<fpage>565</fpage>
					<lpage>573</lpage>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jhep.2015.11.013">https://doi.org/10.1016/j.jhep.2015.11.013</ext-link>
				</element-citation>
			</ref>
			<ref id="B4">
				<mixed-citation>Hui W, Wei L, Li Z, Guo X. Treatment of Hepatitis E, in: Wang, Y. (Ed.), Hepatitis E Virus. Dordrecht: Springer Netherlands, 2016. p. 211-221.</mixed-citation>
				<element-citation publication-type="book">
					<person-group person-group-type="author">
						<name>
							<surname>Hui</surname>
							<given-names>W</given-names>
						</name>
						<name>
							<surname>Wei</surname>
							<given-names>L</given-names>
						</name>
						<name>
							<surname>Li</surname>
							<given-names>Z</given-names>
						</name>
						<name>
							<surname>Guo</surname>
							<given-names>X</given-names>
						</name>
					</person-group>
					<chapter-title>Treatment of Hepatitis E</chapter-title>
					<person-group person-group-type="editor">
						<name>
							<surname>Wang</surname>
							<given-names>Y</given-names>
						</name>
					</person-group>
					<source>Hepatitis E Virus</source>
					<publisher-loc>Dordrecht</publisher-loc>
					<publisher-name>Springer Netherlands</publisher-name>
					<year>2016</year>
					<fpage>211</fpage>
					<lpage>221</lpage>
				</element-citation>
			</ref>
			<ref id="B5">
				<mixed-citation>Johne R, Trojnar E, Filter M, Hofmann J. Thermal stability of hepatitis E virus as estimated by a cell culture method. Appl. Environ. Microbiol. 2016;82(14):4225-4231. Doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/AEM.00951-16">https://doi.org/10.1128/AEM.00951-16</ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Johne</surname>
							<given-names>R</given-names>
						</name>
						<name>
							<surname>Trojnar</surname>
							<given-names>E</given-names>
						</name>
						<name>
							<surname>Filter</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Hofmann</surname>
							<given-names>J</given-names>
						</name>
					</person-group>
					<article-title>Thermal stability of hepatitis E virus as estimated by a cell culture method</article-title>
					<source>Appl. Environ. Microbiol</source>
					<year>2016</year>
					<volume>82</volume>
					<issue>14</issue>
					<fpage>4225</fpage>
					<lpage>4231</lpage>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/AEM.00951-16">https://doi.org/10.1128/AEM.00951-16</ext-link>
				</element-citation>
			</ref>
			<ref id="B6">
				<mixed-citation>Jothikumar N, Cromeans TL, Robertson BH, Meng XJ, Hill VR. A broadly reactive one-step real-time RT-PCR assay for rapid and sensitive detection of hepatitis E virus. J. Virol. Methods. 2006;131(1):65-71. Doi: <ext-link ext-link-type="uri" xlink:href="https//doi.org/10.1016/j.jviromet.2005.07.004">https//doi.org/10.1016/j.jviromet.2005.07.004</ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Jothikumar</surname>
							<given-names>N</given-names>
						</name>
						<name>
							<surname>Cromeans</surname>
							<given-names>TL</given-names>
						</name>
						<name>
							<surname>Robertson</surname>
							<given-names>BH</given-names>
						</name>
						<name>
							<surname>Meng</surname>
							<given-names>XJ</given-names>
						</name>
						<name>
							<surname>Hill</surname>
							<given-names>VR</given-names>
						</name>
					</person-group>
					<article-title>A broadly reactive one-step real-time RT-PCR assay for rapid and sensitive detection of hepatitis E virus</article-title>
					<source>J. Virol. Methods</source>
					<year>2006</year>
					<volume>131</volume>
					<issue>1</issue>
					<fpage>65</fpage>
					<lpage>71</lpage>
					<ext-link ext-link-type="uri" xlink:href="https//doi.org/10.1016/j.jviromet.2005.07.004">https//doi.org/10.1016/j.jviromet.2005.07.004</ext-link>
				</element-citation>
			</ref>
			<ref id="B7">
				<mixed-citation>Li TC, Yoshizaki S, Yang T, Kataoka M, Nakamura T, Ami Y, <italic>et al</italic>. Production of infectious ferret hepatitis E virus in a human hepatocarcinoma cell line PLC/PRF/5. Virus Res. 2016;213:283-288. Doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.virusres.2015.11.027">https://doi.org/10.1016/j.virusres.2015.11.027</ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Li</surname>
							<given-names>TC</given-names>
						</name>
						<name>
							<surname>Yoshizaki</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Yang</surname>
							<given-names>T</given-names>
						</name>
						<name>
							<surname>Kataoka</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Nakamura</surname>
							<given-names>T</given-names>
						</name>
						<name>
							<surname>Ami</surname>
							<given-names>Y</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>Production of infectious ferret hepatitis E virus in a human hepatocarcinoma cell line PLC/PRF/5</article-title>
					<source>Virus Res</source>
					<year>2016</year>
					<volume>213</volume>
					<fpage>283</fpage>
					<lpage>288</lpage>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.virusres.2015.11.027">https://doi.org/10.1016/j.virusres.2015.11.027</ext-link>
				</element-citation>
			</ref>
			<ref id="B8">
				<mixed-citation>Lorenzo FR, Tanaka T, Takahashi H, Ichiyama K, Hoshino Y, Yamada K, <italic>et al</italic>. Mutational events during the primary propagation and consecutive passages of hepatitis E virus strain JE03-1760F in cell culture. Virus Res. 2008;137(1):86-96. Doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.virusres.2008.06.005">https://doi.org/10.1016/j.virusres.2008.06.005</ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Lorenzo</surname>
							<given-names>FR</given-names>
						</name>
						<name>
							<surname>Tanaka</surname>
							<given-names>T</given-names>
						</name>
						<name>
							<surname>Takahashi</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Ichiyama</surname>
							<given-names>K</given-names>
						</name>
						<name>
							<surname>Hoshino</surname>
							<given-names>Y</given-names>
						</name>
						<name>
							<surname>Yamada</surname>
							<given-names>K</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>Mutational events during the primary propagation and consecutive passages of hepatitis E virus strain JE03-1760F in cell culture</article-title>
					<source>Virus Res</source>
					<year>2008</year>
					<volume>137</volume>
					<issue>1</issue>
					<fpage>86</fpage>
					<lpage>96</lpage>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.virusres.2008.06.005">https://doi.org/10.1016/j.virusres.2008.06.005</ext-link>
				</element-citation>
			</ref>
			<ref id="B9">
				<mixed-citation>Meister TL, Bruening J, Todt D, Steinmann E. Cell culture systems for the study of hepatitis E virus. Antiviral Res. 2019;163:34-49. Doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.antiviral.2019.01.007">https://doi.org/10.1016/j.antiviral.2019.01.007</ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Meister</surname>
							<given-names>TL</given-names>
						</name>
						<name>
							<surname>Bruening</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Todt</surname>
							<given-names>D</given-names>
						</name>
						<name>
							<surname>Steinmann</surname>
							<given-names>E</given-names>
						</name>
					</person-group>
					<article-title>Cell culture systems for the study of hepatitis E virus</article-title>
					<source>Antiviral Res</source>
					<year>2019</year>
					<volume>163</volume>
					<fpage>34</fpage>
					<lpage>49</lpage>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.antiviral.2019.01.007">https://doi.org/10.1016/j.antiviral.2019.01.007</ext-link>
				</element-citation>
			</ref>
			<ref id="B10">
				<mixed-citation>Mirazo S, Ramos N, Russi JC, Arbiza J. Genetic heterogeneity and subtyping of human Hepatitis E virus isolates from Uruguay. Virus Res. 2013;173(2):364-370. Doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.virusres.2013.01.005">https://doi.org/10.1016/j.virusres.2013.01.005</ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Mirazo</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Ramos</surname>
							<given-names>N</given-names>
						</name>
						<name>
							<surname>Russi</surname>
							<given-names>JC</given-names>
						</name>
						<name>
							<surname>Arbiza</surname>
							<given-names>J</given-names>
						</name>
					</person-group>
					<article-title>Genetic heterogeneity and subtyping of human Hepatitis E virus isolates from Uruguay</article-title>
					<source>Virus Res</source>
					<year>2013</year>
					<volume>173</volume>
					<issue>2</issue>
					<fpage>364</fpage>
					<lpage>370</lpage>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.virusres.2013.01.005">https://doi.org/10.1016/j.virusres.2013.01.005</ext-link>
				</element-citation>
			</ref>
			<ref id="B11">
				<mixed-citation>Mirazo S, Gardinali NR, Cecilia D, Verger L, Ottonelli F, Ramos N, <italic>et al</italic>. Serological and virological survey of hepatitis E virus (HEV) in animal reservoirs from Uruguay reveals elevated prevalences and a very close phylogenetic relationship between swine and human strains. Vet. Microbiol. 2018;213:21-27. Doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.vetmic.2017.11.013">https://doi.org/10.1016/j.vetmic.2017.11.013</ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Mirazo</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Gardinali</surname>
							<given-names>NR</given-names>
						</name>
						<name>
							<surname>Cecilia</surname>
							<given-names>D</given-names>
						</name>
						<name>
							<surname>Verger</surname>
							<given-names>L</given-names>
						</name>
						<name>
							<surname>Ottonelli</surname>
							<given-names>F</given-names>
						</name>
						<name>
							<surname>Ramos</surname>
							<given-names>N</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>Serological and virological survey of hepatitis E virus (HEV) in animal reservoirs from Uruguay reveals elevated prevalences and a very close phylogenetic relationship between swine and human strains</article-title>
					<source>Vet. Microbiol</source>
					<year>2018</year>
					<volume>213</volume>
					<fpage>21</fpage>
					<lpage>27</lpage>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.vetmic.2017.11.013">https://doi.org/10.1016/j.vetmic.2017.11.013</ext-link>
				</element-citation>
			</ref>
			<ref id="B12">
				<mixed-citation>Qi Y, Zhang F, Zhang L, Harrison TJ, Huang W, Zhao C, <italic>et al</italic>. Hepatitis e virus produced from cell culture has a lipid envelope. PLoS One. 2015;10:1-15. Doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0132503">https://doi.org/10.1371/journal.pone.0132503</ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Qi</surname>
							<given-names>Y</given-names>
						</name>
						<name>
							<surname>Zhang</surname>
							<given-names>F</given-names>
						</name>
						<name>
							<surname>Zhang</surname>
							<given-names>L</given-names>
						</name>
						<name>
							<surname>Harrison</surname>
							<given-names>TJ</given-names>
						</name>
						<name>
							<surname>Huang</surname>
							<given-names>W</given-names>
						</name>
						<name>
							<surname>Zhao</surname>
							<given-names>C</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>Hepatitis e virus produced from cell culture has a lipid envelope</article-title>
					<source>PLoS One</source>
					<year>2015</year>
					<volume>10</volume>
					<issue>1-15</issue>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0132503">https://doi.org/10.1371/journal.pone.0132503</ext-link>
				</element-citation>
			</ref>
			<ref id="B13">
				<mixed-citation>Rogée S, Talbot N, Caperna T, Bouquet J, Barnaud E, Pavio N. New models of hepatitis E virus replication in human and porcine hepatocyte cell lines. J. Gen. Virol. 2013;94(3):549-558. Doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1099/vir.0.049858-0">https://doi.org/10.1099/vir.0.049858-0</ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Rogée</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Talbot</surname>
							<given-names>N</given-names>
						</name>
						<name>
							<surname>Caperna</surname>
							<given-names>T</given-names>
						</name>
						<name>
							<surname>Bouquet</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Barnaud</surname>
							<given-names>E</given-names>
						</name>
						<name>
							<surname>Pavio</surname>
							<given-names>N</given-names>
						</name>
					</person-group>
					<article-title>New models of hepatitis E virus replication in human and porcine hepatocyte cell lines</article-title>
					<source>J. Gen. Virol</source>
					<year>2013</year>
					<volume>94</volume>
					<issue>3</issue>
					<fpage>549</fpage>
					<lpage>558</lpage>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1099/vir.0.049858-0">https://doi.org/10.1099/vir.0.049858-0</ext-link>
				</element-citation>
			</ref>
			<ref id="B14">
				<mixed-citation>Schemmerer M, Johne R, Erl M, Jilg W, Wenzel JJ. Isolation of Subtype 3c, 3e and 3f-Like Hepatitis E virus strains stably replicating to high viral loads in an optimized cell culture system. Viruses. 2019;11(6):483. Doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3390/v11060483">https://doi.org/10.3390/v11060483</ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Schemmerer</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Johne</surname>
							<given-names>R</given-names>
						</name>
						<name>
							<surname>Erl</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Jilg</surname>
							<given-names>W</given-names>
						</name>
						<name>
							<surname>Wenzel</surname>
							<given-names>JJ</given-names>
						</name>
					</person-group>
					<article-title>Isolation of Subtype 3c, 3e and 3f-Like Hepatitis E virus strains stably replicating to high viral loads in an optimized cell culture system</article-title>
					<source>Viruses</source>
					<year>2019</year>
					<volume>11</volume>
					<issue>6</issue>
					<fpage>483</fpage>
					<lpage>483</lpage>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3390/v11060483">https://doi.org/10.3390/v11060483</ext-link>
				</element-citation>
			</ref>
			<ref id="B15">
				<mixed-citation>Sridhar S, Teng JLL, Chiu TH, Lau SKP, Woo PCY. Hepatitis E virus genotypes and evolution: emergence of camel Hepatitis E w. Int J Mol Sci. 2017;18(4):869. Doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3390/ijms18040869">https://doi.org/10.3390/ijms18040869</ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Sridhar</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Teng</surname>
							<given-names>JLL</given-names>
						</name>
						<name>
							<surname>Chiu</surname>
							<given-names>TH</given-names>
						</name>
						<name>
							<surname>Lau</surname>
							<given-names>SKP</given-names>
						</name>
						<name>
							<surname>Woo</surname>
							<given-names>PCY</given-names>
						</name>
					</person-group>
					<article-title>Hepatitis E virus genotypes and evolution: emergence of camel Hepatitis E w</article-title>
					<source>Int J Mol Sci</source>
					<year>2017</year>
					<volume>18</volume>
					<issue>4</issue>
					<fpage>869</fpage>
					<lpage>869</lpage>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3390/ijms18040869">https://doi.org/10.3390/ijms18040869</ext-link>
				</element-citation>
			</ref>
			<ref id="B16">
				<mixed-citation>Shukla P, Nguyen H, Faulk K, Mather K, Torian U, Engle R, Emerson S. Adaptation of a Genotype 3 Hepatitis E virus to efficient growth in cell culture depends on an inserted human gene segment acquired by recombination. J. Virol. 2012;86(10):5697-5707. Doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JVI.00146-12">https://doi.org/10.1128/JVI.00146-12</ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Shukla</surname>
							<given-names>P</given-names>
						</name>
						<name>
							<surname>Nguyen</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Faulk</surname>
							<given-names>K</given-names>
						</name>
						<name>
							<surname>Mather</surname>
							<given-names>K</given-names>
						</name>
						<name>
							<surname>Torian</surname>
							<given-names>U</given-names>
						</name>
						<name>
							<surname>Engle</surname>
							<given-names>R</given-names>
						</name>
						<name>
							<surname>Emerson</surname>
							<given-names>S</given-names>
						</name>
					</person-group>
					<article-title>Adaptation of a Genotype 3 Hepatitis E virus to efficient growth in cell culture depends on an inserted human gene segment acquired by recombination</article-title>
					<source>J. Virol</source>
					<year>2012</year>
					<volume>86</volume>
					<issue>10</issue>
					<fpage>5697</fpage>
					<lpage>5707</lpage>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JVI.00146-12">https://doi.org/10.1128/JVI.00146-12</ext-link>
				</element-citation>
			</ref>
			<ref id="B17">
				<mixed-citation>Takahashi M, Tanaka T, Takahashi H, Hoshino Y, Nagashima S, Jirintai, <italic>et al</italic>. Hepatitis E Virus (HEV) strains in serum samples can replicate efficiently in cultured cells despite the coexistence of HEV antibodies: characterization of HEV virions in blood circulation. J Clin Microbiol. 2010;48(4):1112-1125. Doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JCM.02002-09">https://doi.org/10.1128/JCM.02002-09</ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Takahashi M</surname>
							<given-names>Tanaka T</given-names>
						</name>
						<name>
							<surname>Takahashi H</surname>
							<given-names>Hoshino Y</given-names>
						</name>
						<name>
							<surname>Nagashima S</surname>
							<given-names>Jirintai</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>Hepatitis E Virus (HEV) strains in serum samples can replicate efficiently in cultured cells despite the coexistence of HEV antibodies: characterization of HEV virions in blood circulation</article-title>
					<source>J Clin Microbiol</source>
					<year>2010</year>
					<volume>48</volume>
					<issue>4</issue>
					<fpage>1112</fpage>
					<lpage>1125</lpage>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JCM.02002-09">https://doi.org/10.1128/JCM.02002-09</ext-link>
				</element-citation>
			</ref>
			<ref id="B18">
				<mixed-citation>Takahashi H, Tanaka T, Jirintai S, Nagashima S, Takahashi M, Nishizawa T, <italic>et al</italic>. A549 and PLC/PRF/5 cells can support the efficient propagation of swine and wild boar hepatitis E virus (HEV) strains: demonstration of HEV infectivity of porcine liver sold as food. Arch. Virol. 2012;157(2):235- 246. Doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00705-011-1153-2">https://doi.org/10.1007/s00705-011-1153-2</ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Takahashi</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Tanaka</surname>
							<given-names>T</given-names>
						</name>
						<name>
							<surname>Jirintai</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Nagashima</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Takahashi</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Nishizawa</surname>
							<given-names>T</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>A549 and PLC/PRF/5 cells can support the efficient propagation of swine and wild boar hepatitis E virus (HEV) strains: demonstration of HEV infectivity of porcine liver sold as food</article-title>
					<source>Arch. Virol</source>
					<year>2012</year>
					<volume>157</volume>
					<issue>2</issue>
					<fpage>235</fpage>
					<lpage> 246</lpage>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00705-011-1153-2">https://doi.org/10.1007/s00705-011-1153-2</ext-link>
				</element-citation>
			</ref>
			<ref id="B19">
				<mixed-citation>Von Nordheim M, Boinay M, Leisi R, Kempf C, Ros C. Cutthroat trout virus -towards a virus model to support hepatitis e research. Viruses. 2016;8(10):1-12. Doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/doi:10.3390/v8100289">https://doi.org/doi:10.3390/v8100289 </ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Von Nordheim</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Boinay</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Leisi</surname>
							<given-names>R</given-names>
						</name>
						<name>
							<surname>Kempf</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Ros</surname>
							<given-names>C</given-names>
						</name>
					</person-group>
					<article-title>Cutthroat trout virus -towards a virus model to support hepatitis e research</article-title>
					<source>Viruses</source>
					<year>2016</year>
					<volume>8</volume>
					<issue>10</issue>
					<fpage>1</fpage>
					<lpage>12</lpage>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/doi:10.3390/v8100289">https://doi.org/doi:10.3390/v8100289 </ext-link>
				</element-citation>
			</ref>
			<ref id="B20">
				<mixed-citation>Zhang F, Wang Y. HEV Cell Culture, in: Wang, Y. (Ed.), Hepatitis E Virus. Netherlands, Dordrecht: Springer. 2016. p. 143-159.</mixed-citation>
				<element-citation publication-type="book">
					<person-group person-group-type="author">
						<name>
							<surname>Zhang</surname>
							<given-names>F</given-names>
						</name>
						<name>
							<surname>Wang</surname>
							<given-names>Y</given-names>
						</name>
					</person-group>
					<chapter-title>HEV Cell Culture</chapter-title>
					<person-group person-group-type="editor">
						<name>
							<surname>Wang</surname>
							<given-names>Y</given-names>
						</name>
					</person-group>
					<source>Hepatitis E Virus</source>
					<publisher-loc>Netherlands, Dordrecht</publisher-loc>
					<publisher-name>Springer</publisher-name>
					<year>2016</year>
					<fpage>143</fpage>
					<lpage>159</lpage>
				</element-citation>
			</ref>
		</ref-list>
		<fn-group>
			<fn fn-type="other" id="fn1">
				<label>†</label>
				<p>These authors contributed equally to this work</p>
			</fn>
			<fn fn-type="other" id="fn2">
				<label>Citation/Citar este artículo como:</label>
				<p> Quintero-Gil C, Mirazo S, Parra-Suescún J, López-Herrera A, Mainardi V, Arbiza J, Ordúz S. Cell culture isolation of Hepatitis E Virus Genotype 3 Strain obtained from human feces. Acta biol. Colomb. 2019;24(3):503-508. DOI: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.15446/abc.v24n3.79351">http://dx.doi.org/10.15446/abc.v24n3.79351</ext-link>
				</p>
			</fn>
			<fn fn-type="other" id="fn3">
				<label>Associate Editor:</label>
				<p> María Cristina Navas.</p>
			</fn>
		</fn-group>
		<fn-group>
			<fn fn-type="other" id="fn5">
				<label>CONFLICT OF INTEREST</label>
				<p> The authors declares that there is no conflict of interest.</p>
			</fn>
		</fn-group>
	</back>
</article>